Description: The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many Humira biosimilars in 2023 is the Big Event that will largely determine the impact of the biosimilar wave. Payers have many decisions to make about coverage and formulary tiers. What factors will drive payer decision-making?

Description: A review of the academic article "Health Insurance for ‘Humans’: Information Frictions, Plan Choice, and Consumer Welfare."

Description: Round table discussion regarding the pros and cons of the Affordable Care Act.

Description: This article looks at pharmacy benefit management and the use of data, reviews standard pharmacoeconomic analysis methods, and discusses points for formulary decision making and what is known about the process. From Health Section News, March 2005, Issue No. 49.

Description: SOA’s Pension and Health Sections recently released a new resource model for projecting health care trends through the year 2099.

Description: Financial reconciliation is critical to a successful Medicare Advantage (MA) bid. Reconciliation should be routinely revisited as new information arises.

Description: This article examines the history, theory, and effectiveness of high-deductible health plans and health savings accounts.

Description: Since health care reform has made accountable care organizations a hot topic, an SOA workgroup is addressing relevant questions, including provider risk under various ACO models, limitations of the Medicare model for motivating change in the health care delivery system, strategic priorities, attribution of members, meaurement, and the roles actuaries can play.

Description: Article summarizes the sessions of the 2011 SOA Health Meeting held in Boston.

Description: May 2013 issue of the Health Watch newsletter